Skip to main content

and
  1. Article

    Open Access

    The clinical characteristics, gene mutations and outcomes of myelodysplastic syndromes with diabetes mellitus

    Diabetes mellitus (DM) is the second most common comorbidity in myelodysplastic syndromes (MDS). The purpose of the study was to investigate the clinical characteristics of MDS patients with DM.

    Fanhuan Xu, Jiacheng **, Juan Guo, Feng Xu in Journal of Cancer Research and Clinical On… (2024)

  2. No Access

    Article

    The efficacy and toxicity of the CHG priming regimen (low-dose cytarabine, homoharringtonine, and G-CSF) in higher risk MDS patients relapsed or refractory to decitabine

    Myelodysplastic syndromes (MDSs) refractory or relapsed after hypomethylating agents (HMAs) remain a therapeutic challenge. The CHG regimen has been demonstrated to be effective in initially treating higher ri...

    Cai **u, **ao Li, Lingyun Wu, Feng Xu, Qi He in Journal of Cancer Research and Clinical On… (2019)

  3. No Access

    Article

    Genetic landscape of recurrent ASXL1, U2AF1, SF3B1, SRSF2, and EZH2 mutations in 304 Chinese patients with myelodysplastic syndromes

    We determined the biological and prognostic significance of five recurrent genetic aberrations in Chinese patients with myelodysplastic syndromes (MDS). A total of 304 Chinese MDS patients were screened for kn...

    Lingyun Wu, Luxi Song, Lan Xu, Chunkang Chang, Feng Xu, Dong Wu, Qi He in Tumor Biology (2016)